The marketing study esearch of the range of glucometers on the pharmaceutical market of Ukraine in 2021

Keywords: marketing, glucometer, pharmacy, diabetes, pharmaceutical market of Ukraine

Abstract

Achieving proper glycemic control in patients with diabetes remains a challenge, both in the world and in Ukraine. Self-monitoring of blood glucose with glucometers is recognized as a cost-effective strategy to improve glycemic control.

The aim of the work was to conduct a marketing study of the range of glucometers and test strips in Ukraine to determine their characteristics, configuration and features of use.

The objects of the study were the information of the State Register of Medical Equipment and the offers of pharmacies and online stores available to Ukrainian consumers. Used marketing, analytical, graphical, generalizing analysis.

It is established that in 2021 in Ukraine the range of glucometers is 44 models. Analysis of the device market by country of manufacture showed its import dependence. Most of the market (63.3%) is represented by producers from Asia, the second largest part (27.3%) is represented by European countries and the smallest part is provided by producers from the USA (9.1%). The range consists of 17 types of glucometers, which are encoded automatically, 2 devices – manual and 25 codeless devices. Almost all glucometers available on the market in Ukraine are calibrated by plasma, except for two that are calibrated by whole blood. Measurements with modern glucometers are very fast, mostly 5–6 seconds. Many types of glucometers are equipped with special signals: «warning of hypoglycemia» and «alarm» function (reminder of the need for self-monitoring). A small proportion of glucometers measure other blood parameters (cholesterol, hemoglobin, uric acid and ketones). Appropriate test strips for each meter model and their shelf life have been determined.

A multifaceted marketing research of glucometers, test strips and finger piercing devices on the Ukrainian market was conducted. The analysis of the market of devices for self-control by the country of the manufacturer showed its import dependence. It is established that the wide range, features of application, additional functions and complete set of glucometers give the chance to patients with a diabetes mellitus to choose the necessary device for self-control which will fully satisfy its needs and requirements. Knowledge of the features of glucometers is an important aspect for pharmacists in providing pharmaceutical services to patients with diabetes.

References

International diabetes federation Diabetes Atlas – 9th edition. URL: http://www. diabetesatlas.org

Nathan D., Genuth S., Lachin J. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus // N Engl. J. Med. – 1993. – V. 329. – P. 977–986.

Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the diabetes control and complications trial cohort // Diabetes Care. – 1999. – V. 22. – P. 99–111.

IDF European Region «A Guide to type 1 (insulin-dependent) Diabetes Melitus». European Diabetes Policy Group 1998. URL: http://www.diabetesguidelines.com/health/dwk/pro/guidelines/type1/index.asp

IDF «Guideline on Self-Monitoring of Blood Gloocose in Non-Insulin treated Type 2 Diabetes», 2009. – 39 p.

Kovalov A., Vereshchak T., Shtepa A. Analysis of the treatment system and calculation of economic losses from diabetes in Ukraine // Diabet. Ozhyrinnia. Metabol. syndrom. – 2020. – № 6. – S. 45–62.

Miller K., Foster N., Beck R. et al. Current State of Type 1 Diabetes Treatment in the U. S.: Updated Data From the T1D Exchange Clinic Registry // Diabetes Care. – 2015. – V. 38, N 6. – P. 971–978. https://doi.org/10.2337/dc15-0078

Neborachko M., Pkhakadze A., Vlasenko I. Current trends of digital solutions for diabetes management // Diabetes & Metabolic Syndrome: Clinical Research & Reviews. – 2018. – V. 12, N 4. – P. 2997–3003. https://doi.org/10.1016/j.dsx.2018.07.014

Vlasenko I., Davtian L. Pharmaceutical care for patients with diabetes: storage of insulin // Farmats. zhurn. – 2019. – Т. 74, № 5. – S. 21–34. https://doi.org/10.32352/0367-3057.5.19.03

Liyanage J., Dissanayake H., Gamage K. et al. Evaluation of the accuracy and precision of glucometers currently used in Sri Lanka // Diabetes & Metabolic Syndrome: Clinical Research & Reviews. – 2019. – V. 13, N 3. – P. 2184–2188. https://doi.org/10.1016/j.dsx.2019.05.011

Zhang L., Gu C., Ma H. et al. Portable glucose meter: trends in techniques and its potential application in analysis // Anal. Bioanal. Chem. – 2019. – N 411. – P. 21–36. https://doi.org/10.1007/s00216-018-1361-7

Obzor prodazh dyahnostycheskykh pryborov y sredstv v aptekakh za 1 poluhodye 2018. URL: https://dsm.ru/news/508/

Baranova I. I., Breusova S. V., Kovalenko S. M., Chub O. V. Doslidzhennia tovarnoho asortymentu hliukometriv // Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. – 2020. – № 1 (61). – P. 58–66. https://doi.org/10.24959/uekj.20.8

Derzhavnyi reiestr medychnoi tekhniky ta vyrobiv medychnoho pryznachennia. – Rezhym dostupu: http://portal.diklz.gov.ua/PublicSite/PUB/VMList.aspx

D'Orazio P., Burnett R., Fogh-Andersen N. et al. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division // Clin. Chem. Labor. Med. – 2006. – V. 44, N 12. – P. 1486–1490. https://doi.org/10.1515/CCLM.2006.275

American Diabetes Association. Standards of medical care in diabetes 2020 abridged for primary care providers // Clinical Diabetes. – 2020. – V. 38, N 1. – P. 10–38. https://doi.org/10.2337/cd20-as01

Published
2021-08-26
How to Cite
Vlasenko, I. O. (2021). The marketing study esearch of the range of glucometers on the pharmaceutical market of Ukraine in 2021. Farmatsevtychnyi Zhurnal, (4), 32-42. https://doi.org/10.32352/0367-3057.4.21.03
Section
Management of pharmacy